Search is Powered by Google
Cancer / Oncology News

Increased Cancer Risk With Congenital Abnormalities

Main Category: Cancer / Oncology
Also Included In: Genetics
Article Date: 06 Mar 2008 - 3:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:3 stars

3 (1 votes)

Health Professional:2 stars

2 (1 votes)

Article Opinions: 0 posts

There is a 70 % increased risk for cancer among children with congenital abnormalities and this risk continues until young adulthood. Individuals with nervous system malformations, Down's syndrome and multiple birth defects have the highest cancer risk. This is shown by new research that has used data from, among other sources, the Medical Birth Registry at the Norwegian Institute of Public Health (NIPH).

Cancer and congenital abnormalities could have a shared cause, which may be genetic or environmental. A defect may lead to physiological changes or to changes in lifestyle that could, in turn, affect the cancer risk.

The cancer and birth registers in Norway and Sweden, including the Medical Birth Registry at the NIPH, were linked to identify the occurrence of cancer among children with birth defects, their parents and their siblings. Altogether, 5.2 million children and their families were involved in the study.

Cancer risk also in young adults

The results show that there was a 70 % higher risk for cancer among children with congenital abnormalities in Norway and Sweden compared with children without defects. The risk continued into young adulthood. People with malformations in the nervous system had an increased risk for cancer in these organs and people with Down's syndrome had an increased risk for leukaemia. People with birth defects in multiple organ systems also had an increased cancer risk. There was no total increased cancer risk among parents and siblings of children with congenital abnormalities.

Even if there is no shared, genetic pre-disposition for cancer and defects generally, cancer may be a complication for some birth defects.

Reference

Cancer risk in families of children with birth defects. A population based cohort study of 5.2 million children from Norway and Sweden.
Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A
Cancer Epidemiol. Biomarkers Prev. 2008.

Related links

Cancer Risk in Children with Birth Defects and in Their Families: A Population Based Cohort Study of 5.2 Million Children from Norway and Sweden (Abstract from Cancer Epidem. Biomarkers & Prev.)

Norwegian Institute of Public Health




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...